Mariana Kanbe
@mkanbe.bsky.social
Deeply curious about emerging biotechnologies and their experimental and philosophical dimensions. Graduate in Biomedicine (2016) and Philosophy (2025), MSc in Biotechnology (2024). Seeking a PhD position in this inter/transdisciplinary field.
Pinned
Mariana Kanbe
@mkanbe.bsky.social
· Nov 5
Cross‐sectoral citrus sugarcane biorefinery: polyhydroxyalkanoates production in Brazil
Polyhydroxyalkanoates (PHA) are naturally occurring polyesters accumulated by bacteria under conditions of inorganic nutrient limitations and excess carbon. They offer renewable and biodegradable alt...
scijournals.onlinelibrary.wiley.com
Cross‐sectoral citrus sugarcane biorefinery: polyhydroxyalkanoates production in Brazil - Kanbe - 2024 - Biofuels, Bioproducts and Biorefining - Wiley Online Library scijournals.onlinelibrary.wiley.com/doi/10.1002/...
Great HS by NCOB. It draws attention to biomedical developments worth keeping on our radar, not only for experts but for society at large. Among them: enantiomeric organisms, AI-enabled genomics, and emerging tools for human genome synthesis.
In our last blog of 2025, Melissa Haynes Agoro reflects on key themes that have emerged in our horizon scanning work this year. Read it here:🔗 bit.ly/4q8ts6u
Signals and sensemaking: A year of horizon scanning, futures and foresight - Nuffield Council on Bioethics
Melissa Haynes Agoro, Horizon Scanning Coordinator at the Nuffield Council on Bioethics reflects on themes that have emerged in our work this year.
bit.ly
December 19, 2025 at 1:25 PM
Great HS by NCOB. It draws attention to biomedical developments worth keeping on our radar, not only for experts but for society at large. Among them: enantiomeric organisms, AI-enabled genomics, and emerging tools for human genome synthesis.
Biotechnology keeps pushing me back to a basic epistemic question: when research aims at application, how early and in what way should normative goals shape experimental design at the bench?
December 17, 2025 at 12:47 PM
Biotechnology keeps pushing me back to a basic epistemic question: when research aims at application, how early and in what way should normative goals shape experimental design at the bench?
December 16, 2025 at 11:32 AM
I discovered this podcast yesterday, this is such a nice episode, it seems really interesting studying cultural differences by posing meaningful socio-philosophical questions like those of bioethics (1/2)
open.spotify.com/episode/2WDX...
open.spotify.com/episode/2WDX...
December 13, 2025 at 10:30 PM
I discovered this podcast yesterday, this is such a nice episode, it seems really interesting studying cultural differences by posing meaningful socio-philosophical questions like those of bioethics (1/2)
open.spotify.com/episode/2WDX...
open.spotify.com/episode/2WDX...
Last week at Biorefineries Powered by Renewable Energies: great talks on biorefinery approaches for energy, materials, food/feed, and other biomass uses. A recurring theme: no one-size-fits-all solution, but advantages to context-aware systems adapting to local biomass and changing conditions.
December 12, 2025 at 5:02 PM
Last week at Biorefineries Powered by Renewable Energies: great talks on biorefinery approaches for energy, materials, food/feed, and other biomass uses. A recurring theme: no one-size-fits-all solution, but advantages to context-aware systems adapting to local biomass and changing conditions.
can organoids/assembloids actually suffer? could we consider that mature ones might have some kind of simple consciousness? if that’s the case, is it (bio)ethical to use them for biomedical research? maybe okay for testing drugs to treat disease, but not for enhancement? where do we draw the line?
Brain organoids are getting better at mimicking brains in a dish. But how good is too good? I take a look at the latest developments in my story today in the Times. Gift link: nyti.ms/496PPnC
nyti.ms
November 7, 2025 at 2:22 PM
can organoids/assembloids actually suffer? could we consider that mature ones might have some kind of simple consciousness? if that’s the case, is it (bio)ethical to use them for biomedical research? maybe okay for testing drugs to treat disease, but not for enhancement? where do we draw the line?
Cross‐sectoral citrus sugarcane biorefinery: polyhydroxyalkanoates production in Brazil - Kanbe - 2024 - Biofuels, Bioproducts and Biorefining - Wiley Online Library scijournals.onlinelibrary.wiley.com/doi/10.1002/...
Cross‐sectoral citrus sugarcane biorefinery: polyhydroxyalkanoates production in Brazil
Polyhydroxyalkanoates (PHA) are naturally occurring polyesters accumulated by bacteria under conditions of inorganic nutrient limitations and excess carbon. They offer renewable and biodegradable alt...
scijournals.onlinelibrary.wiley.com
November 5, 2025 at 3:02 PM
Cross‐sectoral citrus sugarcane biorefinery: polyhydroxyalkanoates production in Brazil - Kanbe - 2024 - Biofuels, Bioproducts and Biorefining - Wiley Online Library scijournals.onlinelibrary.wiley.com/doi/10.1002/...